LEGISLATION/H.R. 4101

Cancer Drug Parity Act of 2025

119-HR-4101119th CongressIntroduced Jun 24, 2025Health
Market Probability
No market
Status
Introduced
Committee
Floor Vote
Other Chamber
Signed
Referred to the House Committee on Education and Workforce.

Sponsor

Rep. Grothman, Glenn [R-WI-6](R-WI-6)
27 cosponsors

Actions (3)

Referred to the House Committee on Education and Workforce.
Jun 24, 2025House floor actions
Introduced in House
Jun 24, 2025Library of Congress
Introduced in House
Jun 24, 2025Library of Congress